Illustration: Aïda Amer/Axios
Sycamore Partners is in talks to take Walgreens private, WSJ reports — but the PE firm likely can't do it alone.
Why it matters: There's room for a health-focused sponsor or a strategic in distribution to stake their claims in Walgreens' more profitable divisions.
